Sandra Jackson

About Jackson Sandra

This author has not yet filled in any details.
So far Jackson Sandra has created 44 blog entries.

How did physicians use a discovery from a recent #clinicaltrial to save the life of a boy with a dangerous skin condition?

Using a discovery involving the boy’s own stem cells, physicians were able to save the life of a boy with a dangerous genetic skin condition. The patient, who was suffering from junctional epidermolysis bullosa, in which the skin sheds the epidermis, had lost over eighty percent of his top layer of skin. Through the growth […]

2017-11-29T06:24:47-04:00December 5, 2017|General|

How is the FDA widening the scope of the Reagan Udall Expanded Access Navigator to assist patients with rare or orphan diseases?

Patients with rare diseases face unique challenges. Often, there may be no FDA approved treatments for them, or the patient population with an orphan disease is very small – it may be difficult to find clinical trials developing medicine for their diseases. For this reason, the FDA is expanding the use of the Reagan-Udall Foundation’s […]

2017-11-29T06:24:53-04:00December 1, 2017|General|

How can you further WCGF’s mission to educate, include and provide access?

Today is Giving Tuesday – a day to remember that much of the good in the world is undertaken by not-for-profit organizations. WCG Foundation’s goals in expanded access, ethical training for medical research professionals, and encouraging greater minority participation in clinical trials, are supported by good people – donors make the difference. Please give today […]

2017-11-07T12:21:48-04:00November 28, 2017|General|

For heart attack patients unwilling to enroll in traditional rehabilitation programs, what could be a good alternative?

The American Heart Association has recently reported a study in which patients who have suffered a heart attack, and were unwilling or unable to enroll in cardiac rehabilitation programs, had success with tai chi. Those in the group of patients who were attending tai chi practices more often performed more moderate-to-vigorous physical activity over a […]

2017-11-07T12:22:02-04:00November 24, 2017|General|

How can immunotherapies for cancer treatment be further developed and encouraged?

The NIH and a consortium of biotechnical companies have created PACT, or the Partnership for Accelerating Cancer Therapies, to encourage the development of new immune based treatments for cancer. In some types of cancer, immunotherapies have created dramatic change in the success of treatment. Who is involved in PACT? And what are its goals?

2017-11-07T12:21:57-04:00November 21, 2017|General|

Can expanded access give insight into the future success or failure of a new treatment?

As patients who are receiving treatments via expanded access for diseases are outside of the controlled environment of a clinical trial, their experiences may be considered to be more “real-world.” A multi-national chart review has shown that the success of treatments given through expanded access was mirrored in clinical trials, then after approval and mass […]

2017-11-07T12:22:07-04:00November 17, 2017|General|

How could research of stem cells improve the delivery of cancer drugs to metastatic tumors?

Recent research of stem cells in mice has produced a more precise way to deliver chemotherapy to the tumor microenvironment of metastatic cancer. As opposed to targeting cancer cells directly, as other stem cell research has aimed to achieve, this delivery method targets the cells in their home, which could have a greater effect on […]

2017-11-07T12:22:13-04:00November 14, 2017|General|

Could wider inclusion of minority patients in clinical trials actually lower the cost of healthcare overall?

Lack of accurate data regarding potential side effects or differences in effectiveness in treatments between white Americans and patients of different ethnic backgrounds often leads to less affordable options of care. When drugs have been studied, and minorities left out, treatments that are less effective could lead to greater numbers of hospitalizations, driving up the […]

2017-11-07T12:22:35-04:00November 10, 2017|General|

New Waiver in IRB Process Speeds FDA Single Patient Expanded Access Approval; Updated Information available on WCGF website.

On October 3, 2017, Dr. Scott Gottlieb, FDA Commissioner, testified before the US House of Representatives Subcommittee on Health, Committee on Energy and Commerce. He announced a significant change to the way that IRB may review single patient expanded access request involving investigational drugs or biologics.

This change, which permits an IRB chair or designee to […]

2018-05-25T16:30:55-04:00November 8, 2017|General|
Load More Posts